MICROBOT MEDICAL INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
MICROBOT MEDICAL INC. (MBOT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2022-03-31
- MICROBOT MEDICAL INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2020-03-31 was 0.00%.
- MICROBOT MEDICAL INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2019-03-31 was 0.00%.
- MICROBOT MEDICAL INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2018-03-31 was 0.00%.
- MICROBOT MEDICAL INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2021 was 0.00%.
- MICROBOT MEDICAL INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2020 was 0.00%.
- MICROBOT MEDICAL INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2019 was 0.00%.
- MICROBOT MEDICAL INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2018 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2021-12-31 | 0.00% 10-K · filed 2022-03-31 | |||
| 2020-12-31 | 0.00% 10-K · filed 2022-03-31 | |||
| 2020-09-30 | 0.00% 10-Q · filed 2020-11-16 | |||
| 2020-06-30 | 0.00% 10-Q · filed 2020-08-14 | |||
| 2020-03-31 | 0.00% 10-Q · filed 2020-05-15 | |||
| 2019-12-31 | 0.00% 10-K · filed 2021-03-31 | |||
| 2019-09-30 | 0.00% 10-Q · filed 2019-11-14 | |||
| 2019-06-30 | 0.00% 10-Q · filed 2019-08-14 | |||
| 2019-03-31 | 0.00% 10-Q · filed 2019-05-15 | |||
| 2018-12-31 | 0.00% 10-K · filed 2020-04-14 | |||
| 2018-09-30 | 0.00% 10-Q · filed 2018-11-14 | |||
| 2018-06-30 | 0.00% 10-Q · filed 2018-08-14 | |||
| 2018-03-31 | 0.00% 10-Q · filed 2018-05-15 | |||
| 2017-12-31 | 0.00% 10-K · filed 2019-04-01 | |||
| 2017-09-30 | 0.00% 10-Q · filed 2017-11-14 | |||
| 2016-12-31 | 0.00% 10-K · filed 2018-04-02 | |||
| 2015-12-31 | 0.00% 10-K · filed 2017-03-21 | |||
| 2014-12-31 | 0.00% 10-K · filed 2016-03-15 | |||
| 2013-12-31 | 0.00% 10-K · filed 2016-03-15 | |||
| 2012-12-31 | 0.00% 10-K · filed 2015-03-13 | |||
| 2011-12-31 | 0.00% 10-K · filed 2014-03-13 | |||
| 2010-12-31 | 0.00% 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |